SC
BYAH

Scotia Capital’s Park Ha Biological Technology Co BYAH Stock Holding History

Scotia Capital’s Portfolio BYAH Stock Details BYAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15
Closed -$210K – 958
2025
Q2 		$210K Buy
+15
New +$101K ﹤0.01% 791

Other funds holding BYAH

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Scotia Capital's BYAH Position: Q3 2025 in Review

Scotia Capital sold out of Park Ha Biological Technology Co (BYAH) in Q3 2025, closing a stake of 15 shares — an estimated $210K sold.

Scotia Capital first reported a position in BYAH in Q2 2025 and held it in 1 quarter. The position peaked at $210K in Q2 2025. 6 funds tracked by Wall St. Rank hold BYAH as of Q3 2025.

  • Scotia Capital reported no remaining Park Ha Biological Technology Co position as of Q3 2025 after selling out during the quarter.
  • Scotia Capital sold 15 Park Ha Biological Technology Co shares in Q3 2025, an estimated $210K.
  • Scotia Capital first reported a position in Park Ha Biological Technology Co in Q2 2025 and held it in 1 quarter.
  • Scotia Capital's Park Ha Biological Technology Co position peaked at $210K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Park Ha Biological Technology Co as of Q3 2025.

Based on Scotia Capital's 13F filing for Q3 2025, filed 14 Nov 2025.